• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

    8/8/23 1:13:13 PM ET
    $ADEA
    $AHCO
    $AMRS
    $AMSC
    Computer Software: Prepackaged Software
    Technology
    Medical/Nursing Services
    Health Care
    Get the next $ADEA alert in real time by email

    Gainers

    • Nuburu, Inc. (NYSE:BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser technology.
    • Vivos Therapeutics, Inc. (NASDAQ:VVOS) gained 91.1% to $0.4987 after falling more than 10% on Monday.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) shares climbed 87.6% to $6.04 after the company disclosed data for BMB-101.
    • Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) shares jumped 63.9% to $0.1472 after falling over 25% on Monday. The company recently announced its plans to reduce the company's headcount by 78%.
    • Gorilla Technology Group Inc. (NASDAQ:GRRR) rose 32.2% to $2.04 as the company hired Global Economics Group for due diligence, advancing in battle against illegal short selling.
    • Paymentus Holdings, Inc. (NYSE:PAY) shares gained 29.4% to $13.76 after reporting better-than-expected quarterly results.
    • Bionomics Limited (NASDAQ:BNOX) jumped 24% to $1.60.
    • Kyndryl Holdings, Inc. (NYSE:KD) gained 23% to $15.32 after the company raised its FY24 earnings outlook and said it expects its fiscal 2024 adjusted free cash flow will be positive.
    • ePlus inc. (NASDAQ:PLUS) rose 20.8% to $69.99 following better-than-expected quarterly results.
    • Quanterix Corporation (NASDAQ:QTRX) gained 20.4% to $26.17 after reporting upbeat quarterly results.
    • Sterling Infrastructure, Inc. (NASDAQ:STRL) surged 19.9% to $74.12 after reporting upbeat quarterly results.
    • CECO Environmental Corp. (NASDAQ:CECO) rose 19.3% to $14.01 after the company posted upbeat quarterly sales and increased FY23 revenue guidance.
    • Tilray Brands, Inc. (NASDAQ:TLRY) climbed 19% to $2.6484 after the Canadian cannabis and packaged goods company announced a deal to acquire eight beer brands from Anheuser-Busch Inbev.
    • Viant Technology Inc. (NASDAQ:DSP) gained 18.2% to $5.42 following strong quarterly results.
    • Latham Group, Inc. (NASDAQ:SWIM) gained 18.1% to $4.50 following strong quarterly sales.
    • WW International, Inc. (NASDAQ:WW) jumped 18.1% to $9.45.
    • MannKind Corporation (NASDAQ:MNKD) rose 17.7% to $5.41 following strong quarterly results.
    • Novo Nordisk A/S (NYSE:NVO) climbed 17.4% to $189.48 after the company announced headline results from the SELECT cardiovascular outcomes trial showing Semaglutide 2.4 mg reduced risk of major adverse cardiovascular events by 20%.
    • Eli Lilly and Company (NYSE:LLY) rose 16.6% to $529.61 after the company raised its FY23 guidance. The company also reported better-than-expected second-quarter earnings, including strong Mounjaro sales growth.
    • DocGo Inc. (NASDAQ:DCGO) gained 16.3% to $10.59 following upbeat sales.
    • United States Cellular Corporation (NYSE:USM) jumped 15.2% to $36.00. JP Morgan upgraded United States Cellular from Neutral to Overweight.
    • AdaptHealth Corp. (NASDAQ:AHCO) climbed 14.8% to $15.28 following upbeat sales.
    • Telephone and Data Systems, Inc. (NYSE:TDS) gained 14.8% to $15.17. JP Morgan upgraded Telephone and Data from Neutral to Overweight and announced a $38 price target.
    • Structure Therapeutics Inc. (NASDAQ:GPCR) rose 14% to $30.20.
    • CPI Card Group Inc. (NASDAQ:PMTS) jumped 13.4% to $27.42 following strong quarterly results.
    • Cardiff Oncology, Inc. (NASDAQ:CRDF) shares rose 12.1% to $1.76 after the company announced new lead program in first-line metastatic colorectal cancer and expanded Pfizer relationship.
    • James Hardie Industries plc (NYSE:JHX) gained 11.7% to $30.30 following quarterly results.
    • CRISPR Therapeutics AG (NASDAQ:CRSP) surged 11.8% to $54.04 following strong quarterly results.
    • Brookdale Senior Living Inc. (NYSE:BKD) climbed 11.3% to $4.22 following strong quarterly results.
    • Chegg, Inc. (NYSE:CHGG) gained 9.4% to $10.95 after reporting better-than-expected quarterly sales.
    • Novavax, Inc. (NASDAQ:NVAX) surged 7.3% to $ 8.07 following upbeat quarterly results.
    • Hims & Hers Health, Inc. (NASDAQ:HIMS) shares climbed 4.4% to $8.24 after the company posted upbeat second-quarter results and raised full-year revenue forecast.

    Losers

    • Proterra Inc. (NASDAQ:PTRA) shares dipped 79.6% to $0.2912. Proterra filed for Chapter 11 bankruptcy protection on Monday citing market and macroeconomic headwinds.
    • SeaChange International, Inc. (NASDAQ:SEAC) fell 41.3% to $4.62 after the company announced voluntary SEC deregistration and Nasdaq delisting.
    • Datasea Inc. (NASDAQ:DTSS) shares fell 37.5% to $0.7118. Datasea said on August 1 that it entered into two separate subscription agreements with a certain non-U.S. investor to sell an aggregate of 4.8 million shares of common stock at $1.20 per share.
    • Vistagen Therapeutics, Inc. (NASDAQ:VTGN) declined 32.6% to $8.80. The stock appears to be pulling back after soaring more than 675% on Monday.
    • Thoughtworks Holding, Inc. (NASDAQ:TWKS) fell 28.1% to $5.05 after the company reported worse-than-expected second-quarter financial results and issued third-quarter adjusted EPS and revenue guidance below estimates.
    • ESGL Holdings Limited (NASDAQ:ESGL) dipped 26.4% to $5.67.
    • AxoGen, Inc. (NASDAQ:AXGN) fell 25.7% to $6.15 following weak quarterly sales.
    • Amyris, Inc. (NASDAQ:AMRS) declined 25.5% to $0.4441.
    • Save Foods, Inc. (NASDAQ:SVFD) fell 25.4% to $1.1635 after jumping 144% on Monday.
    • Helios Technologies, Inc. (NASDAQ:HLIO) dropped 21.5% to $48.91 following weak quarterly earnings.
    • Blue Star Foods Corp. (NASDAQ:BSFC) tumbled 21% to $0.9899.
    • Beyond Meat, Inc. (NASDAQ:BYND) fell 21% to $12.08 after the company reported downbeat results for its second quarter and issued weak revenue forecast for FY23.
    • Everbridge, Inc. (NASDAQ:EVBG) dipped 21% to $23.00 following downbeat quarterly sales.
    • Missfresh Limited (NASDAQ:MF) fell 20.3% to $2.0704 after jumping around 32% on Monday.
    • MRC Global Inc. (NYSE:MRC) declined 19.2% to $9.01 following weak quarterly results.
    • Datadog, Inc. (NASDAQ:DDOG) fell 18.7% to $86.39 after the company issued Q3 and FY23 revenue guidance below estimates.
    • FlexShopper, Inc. (NASDAQ:FPAY) fell 18.6% to $1.7997.
    • Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) tumbled 18.2% to $26.08 following weak quarterly results.
    • International Flavors & Fragrances Inc. (NYSE:IFF) shares fell 18.2% to $65.74 after the company reported worse-than-expected second-quarter results and issued a reduced FY23 outlook.
    • Adeia Inc. (NASDAQ:ADEA) fell 17.3% to $9.66 following weak quarterly sales.
    • Alteryx, Inc. (NYSE:AYX) fell 17.2% to $31.16 after the company reported second-quarter results and issued weak third-quarter revenue guidance. Piper Sandler downgraded to Neutral from Overweight and lowered the price target to $30 from $68.
    • Rigetti Computing, Inc. (NASDAQ:RGTI) shares declined 16.2% to $1.9450 after falling 15% on Monday.
    • BioNexus Gene Lab Corp. (NASDAQ:BGLC) fell 16.2% to $1.34.
    • iHeartMedia, Inc. (NASDAQ:IHRT) dipped 15.8% to $3.77 following second-quarter results.
    • Olaplex Holdings, Inc. (NASDAQ:OLPX) dropped 15.5% to $3.0150 after the company reported worse-than-expected second-quarter financial results and lowered FY23 outlook.
    • ParaZero Technologies Ltd. (NASDAQ:PRZO) fell 15.2% to $1.7693. ParaZero shares jumped 40% on Monday after the company received a second order for its custom safety system for drones by an automotive manufacturer.
    • RingCentral, Inc. (NYSE:RNG) shares fell 15.2% to $33.04 after the company issued weak earnings forecast for the third quarter and said Vlad Shmunis is stepping down as CEO later.
    • SkyWater Technology, Inc. (NASDAQ:SKYT) declined 14.2% to $8.08 following a wider-than-expected loss.
    • Compass, Inc. (NYSE:COMP) declined 14% to $3.42 after posting disappointing quarterly results.
    • Energizer Holdings, Inc. (NYSE:ENR) fell 13.1% to $31.42 after posting weak quarterly results.
    • Medical Properties Trust, Inc. (NYSE:MPW) declined 12.7% to $8.81 after the company reported worse-than-expected second-quarter sales results.
    • Global-e Online Ltd. (NASDAQ:GLBE) dipped 12.2% to $35.87 after the company issued weak sales forecast.
    • Five9, Inc. (NASDAQ:FIVN) fell 12.2% to $71.66 after the company posted second-quarter results and entered into definitive agreement to acquire Aceyus.
    • PowerSchool Holdings, Inc. (NYSE:PWSC) fell 11.8% to $20.00. PowerSchool reported in-line earnings for its second quarter.
    • Teradata Corporation (NYSE:TDC) declined 11.4% to $49.13 following quarterly results.
    • Li Auto Inc. (NASDAQ:LI) shares fell 10.7% to $41.65 following quarterly results.
    • ICU Medical, Inc. (NASDAQ:ICUI) declined 10.4% to $153.60 after the company reported mixed quarterly financial results.
    • American Superconductor Corporation (NASDAQ:AMSC) shares fell 10.4% to $9.00.
    • Safehold Inc. (NYSE:SAFE) shares fell 8.8% to $21.11 after the company reported pricing of public offering and concurrent private placement.
    • Ingredion Incorporated (NYSE:INGR) dropped 8.2% to $100.57 following weak quarterly results.
    • Sealed Air Corporation (NYSE:SEE) fell 7.4% to $40.79. Sealed Air reported a second-quarter FY23 sales decrease of almost 3% year-on-year to $1.38 billion, missing the consensus of $1.42 billion.
    • Hercules Capital, Inc. (NYSE:HTGC) shares declined 5.6% to $17.02. Hercules Capital upsized its public offering to 6.5 million shares of common stock.

    Now Read This: Bitcoin Rises Above This Key Level; Algorand Emerges As Top Gainer

    Get the next $ADEA alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADEA
    $AHCO
    $AMRS
    $AMSC

    CompanyDatePrice TargetRatingAnalyst
    Novo Nordisk A/S
    $NVO
    3/10/2026$42.00Buy → Hold
    TD Cowen
    Hims & Hers Health Inc.
    $HIMS
    3/10/2026$24.00Sell → Neutral
    Citigroup
    Hims & Hers Health Inc.
    $HIMS
    3/10/2026$23.00Underperform → Neutral
    BofA Securities
    Hims & Hers Health Inc.
    $HIMS
    3/9/2026$30.00Hold → Buy
    Needham
    Novo Nordisk A/S
    $NVO
    3/3/2026$40.00Underweight → Equal-Weight
    Morgan Stanley
    Novo Nordisk A/S
    $NVO
    3/2/2026$41.00Buy → Neutral
    Goldman
    MannKind Corporation
    $MNKD
    2/27/2026$3.50Outperform → Sector Perform
    RBC Capital Mkts
    Eli Lilly and Company
    $LLY
    2/25/2026$1250.00Outperform
    RBC Capital Mkts
    More analyst ratings

    $ADEA
    $AHCO
    $AMRS
    $AMSC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Fribourg Paul J bought $10,971,329 worth of shares (156,459 units at $70.12) and sold $14,481 worth of shares (222 units at $65.23), increasing direct ownership by 92% to 29,650 units (SEC Form 4)

    4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

    3/16/26 4:33:49 PM ET
    $IFF
    Major Chemicals
    Industrials

    Chief Executive Officer Fyrwald J Erik bought $995,204 worth of shares (14,260 units at $69.79), increasing direct ownership by 18% to 91,630 units (SEC Form 4)

    4 - INTERNATIONAL FLAVORS & FRAGRANCES INC (0000051253) (Issuer)

    3/16/26 4:33:47 PM ET
    $IFF
    Major Chemicals
    Industrials

    Large owner Cashin Richard M Jr bought $19,912,148 worth of shares (2,046,691 units at $9.73) (SEC Form 4)

    4 - AdaptHealth Corp. (0001725255) (Issuer)

    3/12/26 9:11:41 PM ET
    $AHCO
    Medical/Nursing Services
    Health Care

    $ADEA
    $AHCO
    $AMRS
    $AMSC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    DocGo Announces Fourth Quarter and Full Year 2025 Results

    Company Raises 2026 Revenue and Adjusted EBITDA Guidance due to Customer Expansions, Improved EMS Hiring Rates and Efficiency Initiatives Company Has Initiated a Formal Process to Explore Strategic Alternatives to Maximize Shareholder Value Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Total revenue for the fourth quarter of 2025 was $74.9 million, compared t

    3/16/26 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Beyond Meat® Reports Delay of Annual Report on Form 10-K for the Full Year Ended December 31, 2025

    EL SEGUNDO, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ:BYND) ("Beyond Meat" or "the Company"), a leader in plant-based meat, announced today that it will delay the filing of its Annual Report on Form 10-K for the full year ended December 31, 2025. The filing is delayed because the Company requires additional time to complete a review and analysis related to its inventory balances, including amounts recorded for the provision of excess and obsolete inventory. The Company continues to work diligently to complete its fourth quarter and full year financial close procedures and has not yet made a determination regarding the potential impact on its financial statements

    3/16/26 4:05:00 PM ET
    $BYND
    Packaged Foods
    Consumer Staples

    Gorilla Technology & Yotta Sign Landmark AI Infrastructure Deal, Establishing Major Position in India's Sovereign AI Buildout

    - Agreement includes an AI infrastructure deployment in India of approx. 640 high-performance servers with more than 5,000 GPUs for AI workloads- This deployment is expected to contribute more than $500 million in revenue over the next five yearsLondon, United Kingdom--(Newsfile Corp. - March 16, 2026) - Gorilla Technology Group Inc. (NASDAQ:GRRR) ("Gorilla" or the "Company"), a global solution provider in Security Intelligence, Network Intelligence, Business Intelligence, IoT technology and data centres, today announced that it has signed binding agreements with Yotta Data Services Private Limited ("Yotta") to deploy GPU infrastructure in India of approximately 640 high-perf

    3/16/26 8:30:00 AM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    $ADEA
    $AHCO
    $AMRS
    $AMSC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Novo Nordisk A/S downgraded by TD Cowen with a new price target

    TD Cowen downgraded Novo Nordisk A/S from Buy to Hold and set a new price target of $42.00

    3/10/26 8:39:23 AM ET
    $NVO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Hims & Hers Health upgraded by Citigroup with a new price target

    Citigroup upgraded Hims & Hers Health from Sell to Neutral and set a new price target of $24.00

    3/10/26 8:37:35 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    Hims & Hers Health upgraded by BofA Securities with a new price target

    BofA Securities upgraded Hims & Hers Health from Underperform to Neutral and set a new price target of $23.00

    3/10/26 8:37:14 AM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    $ADEA
    $AHCO
    $AMRS
    $AMSC
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    August 30, 2024 - La FDA autoriza la vacuna contra el COVID-19 de Novavax actualizada para brindar una mejor protección contra las variantes que circulan actualmente.

    For Immediate Release: August 30, 2024 English Hoy, la Administración de Alimentos y Medicamentos de los Estados Unidos (FDA, por sus siglas en inglés) otorgó una autorización de uso de emergencia (EUA, por sus siglas en inglés) para una versión actualizada de la vacuna contra el COVID-19 de Novavax que ataca más de cerca a las variantes que circulan actualmente para brindar una mejor protección contra las cons

    9/3/24 2:26:49 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 30, 2024 - FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

    For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of

    8/30/24 2:26:48 PM ET
    $NVAX
    $PFE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    May 31, 2024 - FDA Roundup: May 31, 2024

    For Immediate Release: May 31, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV) in individuals 60 years of age and older. mRESVIA is an mRNA-based vaccine that is manufa

    5/31/24 3:22:42 PM ET
    $LLY
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADEA
    $AHCO
    $AMRS
    $AMSC
    SEC Filings

    View All

    SEC Form 144 filed by Datadog Inc.

    144 - Datadog, Inc. (0001561550) (Subject)

    3/16/26 4:37:34 PM ET
    $DDOG
    Computer Software: Prepackaged Software
    Technology

    SEC Form 10-K filed by DocGo Inc.

    10-K - DocGo Inc. (0001822359) (Filer)

    3/16/26 4:30:59 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    SEC Form NT 10-K filed by Beyond Meat Inc.

    NT 10-K - BEYOND MEAT, INC. (0001655210) (Filer)

    3/16/26 4:17:35 PM ET
    $BYND
    Packaged Foods
    Consumer Staples

    $ADEA
    $AHCO
    $AMRS
    $AMSC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Broida Tzvia claimed ownership of 8,595 units of Ordinary Shares (SEC Form 3)

    3 - Global-E Online Ltd. (0001835963) (Issuer)

    3/16/26 7:06:04 PM ET
    $GLBE
    Computer Software: Prepackaged Software
    Technology

    New insider Koren Ofer claimed ownership of 90,484 units of Ordinary Shares (SEC Form 3)

    3 - Global-E Online Ltd. (0001835963) (Issuer)

    3/16/26 6:48:49 PM ET
    $GLBE
    Computer Software: Prepackaged Software
    Technology

    New insider Tsuchikawa Gen claimed ownership of 14,404 units of Ordinary Shares (SEC Form 3)

    3 - Global-E Online Ltd. (0001835963) (Issuer)

    3/16/26 6:21:51 PM ET
    $GLBE
    Computer Software: Prepackaged Software
    Technology

    $ADEA
    $AHCO
    $AMRS
    $AMSC
    Financials

    Live finance-specific insights

    View All

    DocGo Announces Fourth Quarter and Full Year 2025 Results

    Company Raises 2026 Revenue and Adjusted EBITDA Guidance due to Customer Expansions, Improved EMS Hiring Rates and Efficiency Initiatives Company Has Initiated a Formal Process to Explore Strategic Alternatives to Maximize Shareholder Value Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Total revenue for the fourth quarter of 2025 was $74.9 million, compared t

    3/16/26 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Beyond Meat® Reports Delay of Annual Report on Form 10-K for the Full Year Ended December 31, 2025

    EL SEGUNDO, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ:BYND) ("Beyond Meat" or "the Company"), a leader in plant-based meat, announced today that it will delay the filing of its Annual Report on Form 10-K for the full year ended December 31, 2025. The filing is delayed because the Company requires additional time to complete a review and analysis related to its inventory balances, including amounts recorded for the provision of excess and obsolete inventory. The Company continues to work diligently to complete its fourth quarter and full year financial close procedures and has not yet made a determination regarding the potential impact on its financial statements

    3/16/26 4:05:00 PM ET
    $BYND
    Packaged Foods
    Consumer Staples

    Weight Watchers Announces Fourth Quarter and Full Year 2025 Results

    2025 Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over-year with continued growth in first quarter 2026  Fourth Quarter Total Revenue of $163 million; Clinical Subscription Revenue of $27 million, up 32% year-over-year Fourth Quarter Net Loss of $6 million; Net Loss Margin of 3.6%; Adjusted EBITDA1 of $18 million and Adjusted EBITDA Margin1 of 11.1% Provides First Quarter 2026 End of Period Subscriber Estimates and Full Year 2026 Financial Guidance NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weigh

    3/16/26 7:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    $ADEA
    $AHCO
    $AMRS
    $AMSC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Paymentus Holdings Inc.

    SC 13G - Paymentus Holdings, Inc. (0001841156) (Subject)

    12/10/24 5:08:45 PM ET
    $PAY
    Real Estate

    Amendment: SEC Form SC 13G/A filed by CRISPR Therapeutics AG

    SC 13G/A - CRISPR Therapeutics AG (0001674416) (Subject)

    12/10/24 1:34:45 PM ET
    $CRSP
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by Gorilla Technology Group Inc.

    SC 13G/A - Gorilla Technology Group Inc. (0001903145) (Subject)

    12/6/24 9:25:12 PM ET
    $GRRR
    Computer Software: Prepackaged Software
    Technology

    $ADEA
    $AHCO
    $AMRS
    $AMSC
    Leadership Updates

    Live Leadership Updates

    View All

    Hims & Hers Names Kathryn Beiser as Chief Communications Officer

    The global communications leader, who previously held roles at Eli Lilly and Kaiser Permanente, joins the world's leading consumer health platform in its next phase of growth Hims & Hers Health, Inc. (NYSE:HIMS), the leading global health and wellness platform, today announced the appointment of Kathryn Beiser as Chief Communications Officer. In this role, Beiser will lead external and internal communications for the company as it enters a new phase of domestic and international growth. In her role as CCO, Beiser will report to CEO Andrew Dudum and focus on continuing to build the Hims & Hers brand and reputation while helping the industry understand the company's expansive vision for the

    3/10/26 8:08:00 PM ET
    $HIMS
    Medical/Nursing Services
    Health Care

    ParaZero Strengthens Global Sales Leadership with Appointment of Bat-Sheva Noy as VP

    Kfar Saba, Israel, March 04, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (NASDAQ:PRZO) (the "company" or "ParaZero"), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, recently announced the appointment of Bat-Sheva Noy as its new Vice President of Global Sales. Ms. Noy brings more than 20 years of extensive commercial and leadership experience, with particular expertise in strategic planning, market access, and leading cross-functional teams. Most recently, from 2020 to 2025, she served as the Business Unit Lead for Rare Diseases at Pfizer Israel ((a subsidiary of Pfizer Inc., NYSE:PFE). In that

    3/4/26 8:32:00 AM ET
    $PFE
    $PRZO
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Military/Government/Technical
    Industrials

    Datadog Appoints Dominic Phillips to Its Board of Directors

    NEW YORK, March 02, 2026 (GLOBE NEWSWIRE) -- Datadog, Inc., (NASDAQ:DDOG), the leading AI-powered observability and security platform for cloud applications, today announced the appointment of Dominic Phillips to its Board of Directors. "As AI compounds complexity for businesses across the globe, Datadog's vision for driving autonomy while providing full-stack visibility and security across all applications stands out in the industry," said Phillips. "I'm looking forward to bringing my expertise and knowledge in scaling high-growth companies to help further this vision." "Dominic has a strong track record of leading rapidly growing global technology companies. His experience building hig

    3/2/26 4:30:00 PM ET
    $DDOG
    Computer Software: Prepackaged Software
    Technology